MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-02-2023
NuVasive Retained Earnings 2011-2026 | NUVA
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 86.1 M | 45.7 M | 45.3 M | 82.5 M | 17.2 M | 4.5 M | -66.9 M | -121 M | -187 M | -170 M | -178 M | -181 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 86.1 M | -187 M | -51.9 M |
Quarterly Retained Earnings NuVasive
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92.5 M | 85.1 M | 86.1 M | 62 M | - | 64.9 M | 45.7 M | 82.4 M | 104 M | 102 M | 45.3 M | 45.3 M | 45.3 M | 45.3 M | 82.5 M | 82.5 M | 82.5 M | 82.5 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 4.76 M | 4.76 M | 4.76 M | 4.76 M | -66.9 M | -66.9 M | -66.9 M | -66.9 M | -104 M | -104 M | -104 M | -121 M | -187 M | -187 M | -187 M | -187 M | -170 M | -170 M | -170 M | -170 M | -178 M | -178 M | -178 M | -178 M | -181 M | -181 M | -181 M | -181 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 104 M | -187 M | -45.8 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B |  USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | - | - | $ 1.05 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.6 | 4.2 % | $ 135 M |  France |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.22 | 2.78 % | $ 1.35 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 11.47 | 3.33 % | $ 325 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 17.12 | 0.47 % | $ 402 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.57 | -5.8 % | $ 35.5 M | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 66.26 | 15.05 % | $ 3.61 B |  Britain |
 |
Delcath Systems
DCTH
|
-529 M | $ 11.26 | -2.34 % | $ 403 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.04 | -0.95 % | $ 17.6 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
21.2 M | - | 0.5 % | $ 219 M | USA |
 |
Myomo
MYO
|
-119 M | $ 0.85 | -2.78 % | $ 35.6 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.55 | -5.6 % | $ 963 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Orthofix Medical
OFIX
|
-368 M | $ 12.19 | -2.01 % | $ 483 M |  Curacao |
 |
Insulet Corporation
PODD
|
287 M | - | - | $ 10.6 B | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 89.22 | -0.9 % | $ 12.1 B | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.4 | -0.83 % | $ 6.66 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 37.32 | 1.86 % | $ 1.16 B | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 45.7 | -5.42 % | $ 1.34 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 86.29 | 0.51 % | $ 3 B | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Stryker Corporation
SYK
|
20.5 B | $ 292.33 | -0.99 % | $ 112 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 83.2 | 0.35 % | $ 48.7 B | USA |
 |
TransMedics Group
TMDX
|
-278 M | - | - | $ 2.48 B | USA |
 |
Tactile Systems Technology
TCMD
|
54.9 M | $ 25.3 | 5.2 % | $ 579 M | USA |
 |
Tandem Diabetes Care
TNDM
|
-1.25 B | - | - | $ 1.23 B | USA |
 |
LENSAR
LNSR
|
-178 M | $ 5.39 | -1.73 % | $ 64.5 M | USA |